OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2024
(3)
2023
(3)
2022
(3)
2021
(2)
2019
(2)
2020
(1)
2015
(1)
2012
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.
Not available
S-EPMC4979103
|
biostudies-literature
Cite
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
Not available
S-EPMC9855296
|
biostudies-literature
Cite
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis.
Not available
S-EPMC7686901
|
biostudies-literature
Cite
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Not available
S-EPMC6839950
|
biostudies-literature
Cite
The International Climate Psychology Collaboration: Climate change-related data collected from 63 countries.
Not available
S-EPMC11445540
|
biostudies-literature
Cite
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.
Not available
S-EPMC9101248
|
biostudies-literature
Cite
Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
Not available
S-EPMC10336619
|
biostudies-literature
Cite
Improving diabetes care: multi-component cardiovascular disease risk reduction strategies for people with diabetes in South Asia--the CARRS multi-center translation trial.
Not available
S-EPMC3544938
|
biostudies-literature
Cite
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Not available
S-EPMC2993160
|
biostudies-literature
Cite
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Not available
S-EPMC6880781
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets